Phibro Animal Health Corporation provided consolidated earnings guidance for the year ending June 30, 2024. For the year, the company expects Net sales of $980 million to $1.02 billion, growth of 2%, Net income of $23 million to $28 million, a decline of 22% and Diluted EPS of $0.57 to $0.69, a decline of 22%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.23 USD | +0.06% | +1.77% | +48.79% |
09/05 | Transcript : Phibro Animal Health Corporation, Q3 2024 Earnings Call, May 09, 2024 | |
08/05 | Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q3 EPS $0.31, vs. Street Est of $0.29 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.79% | 70Cr | |
+22.35% | 900.89Cr | |
+23.12% | 364.06Cr | |
-4.17% | 306.03Cr | |
+13.18% | 165.44Cr | |
-4.88% | 123.45Cr | |
-30.18% | 115.77Cr | |
-31.11% | 114.97Cr | |
-23.45% | 100Cr | |
-11.41% | 93Cr |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024